Condition
Left-Sided Breast Cancer
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Alignrt System Visionrt Ltd London Uk
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT03459898Not ApplicableCompletedPrimary
Assessment of Left-sided Cardiac Sparing Through the Use of 3-dimensional Surface Matching-based Deep Inspiration Breath Hold and Active Breathing Control
NCT03748030UnknownPrimary
Hybrid PET/MR Imaging of Acute Cardiac Inflammation After Left-Sided Breast Cancer Radiotherapy
Showing all 2 trials
Research Network
Common Treatments
- Alignrt System Visionrt Ltd London Uk1
- Confirmed Leftsided Breast Cancer1
Active Sponsors
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
- Sunnybrook Health Sciences Centre1
Top Investigators
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Related Conditions
- Radiation Toxicity1